25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells
<p>Abstract</p> <p>Background</p> <p>25-hydroxycholesterol (25-HC) is one of the oxysterols, which are oxidized derivatives of cholesterol, and has been reported to be involved in the pathogenesis of atherosclerosis and Alzheimer’s disease. In lung, the possible involve...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | Respiratory Research |
| Subjects: | |
| Online Access: | http://respiratory-research.com/content/13/1/63 |
| _version_ | 1818211219673186304 |
|---|---|
| author | Koarai Akira Yanagisawa Satoru Sugiura Hisatoshi Ichikawa Tomohiro Kikuchi Takashi Furukawa Kanako Akamatsu Keiichiro Hirano Tsunahiko Nakanishi Masanori Matsunaga Kazuto Minakata Yoshiaki Ichinose Masakazu |
| author_facet | Koarai Akira Yanagisawa Satoru Sugiura Hisatoshi Ichikawa Tomohiro Kikuchi Takashi Furukawa Kanako Akamatsu Keiichiro Hirano Tsunahiko Nakanishi Masanori Matsunaga Kazuto Minakata Yoshiaki Ichinose Masakazu |
| author_sort | Koarai Akira |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>25-hydroxycholesterol (25-HC) is one of the oxysterols, which are oxidized derivatives of cholesterol, and has been reported to be involved in the pathogenesis of atherosclerosis and Alzheimer’s disease. In lung, the possible involvement of 25-HC in airway diseases has been revealed. In the present study, we examined whether 25-HC affects the release of cytokines and also modulates the responses of toll-like receptor 3 (TLR3) in airway epithelial cells.</p> <p>Methods</p> <p>The effect of 25-HC on the release of cytokines from primary human bronchial epithelial cells after stimulation with or without polyinosine-polycytidylic acid [poly(I:C)], a ligand for TLR3, and the signal transduction were examined.</p> <p>Results</p> <p>25-HC significantly potentiated the release of interleukin-8 (IL-8) and IL-6 from the cells. This effect was more potent compared with that of other oxysterols, 22-HC and 27-HC. GW3965 and TO901317, synthetic agonists of liver X receptors that are receptors for oxysterols, did not augment the IL-8 release. 25-HC enhanced the nuclear factor-kappa B (NF-κB) DNA binding activity and translocation of phosphorylated c-Jun into the nucleus. The release of IL-8 was inhibited by the NF-κB inhibitor, caffeic acid phenethyl ester (CAPE), an inhibitor of nuclear factor kappa-B alpha (IκBα) inhibitor, BAY 11–7085, and an inhibitor of nuclear factor kappa-B kinase-2 (IKK-2) inhibitor, SC-514, but not by a c-Jun N-terminal kinase (JNK) inhibitory peptide, L-JNKi1. 25-HC significantly potentiated IL-8 release in poly(I:C)-treated cells and the augmentation was inhibited by CAPE, BAY 11–7085, and SC-514. Furthermore, 25-HC potentiated the translocation of interferon regulatory factor 3 into the nucleus and the release of interferon-beta (IFN-β) in poly(I:C)-treated cells.</p> <p>Conclusions</p> <p>These data demonstrated that 25-HC augments the release of IL-8 and IL-6 via NF-κB signalling pathway and enhances the release of IL-8 and IFN-β after stimulation of TLR3 in airway epithelial cells. 25-HC may be involved in the neutrophilic airway inflammation through the stimulant effect of IL-8 and IL-6 release and also potentiate the TLR3-mediated innate immunity in airway diseases.</p> |
| first_indexed | 2024-12-12T05:29:01Z |
| format | Article |
| id | doaj.art-b08c02132574446482cf567339353cb3 |
| institution | Directory Open Access Journal |
| issn | 1465-9921 |
| language | English |
| last_indexed | 2024-12-12T05:29:01Z |
| publishDate | 2012-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Respiratory Research |
| spelling | doaj.art-b08c02132574446482cf567339353cb32022-12-22T00:36:22ZengBMCRespiratory Research1465-99212012-07-011316310.1186/1465-9921-13-6325-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cellsKoarai AkiraYanagisawa SatoruSugiura HisatoshiIchikawa TomohiroKikuchi TakashiFurukawa KanakoAkamatsu KeiichiroHirano TsunahikoNakanishi MasanoriMatsunaga KazutoMinakata YoshiakiIchinose Masakazu<p>Abstract</p> <p>Background</p> <p>25-hydroxycholesterol (25-HC) is one of the oxysterols, which are oxidized derivatives of cholesterol, and has been reported to be involved in the pathogenesis of atherosclerosis and Alzheimer’s disease. In lung, the possible involvement of 25-HC in airway diseases has been revealed. In the present study, we examined whether 25-HC affects the release of cytokines and also modulates the responses of toll-like receptor 3 (TLR3) in airway epithelial cells.</p> <p>Methods</p> <p>The effect of 25-HC on the release of cytokines from primary human bronchial epithelial cells after stimulation with or without polyinosine-polycytidylic acid [poly(I:C)], a ligand for TLR3, and the signal transduction were examined.</p> <p>Results</p> <p>25-HC significantly potentiated the release of interleukin-8 (IL-8) and IL-6 from the cells. This effect was more potent compared with that of other oxysterols, 22-HC and 27-HC. GW3965 and TO901317, synthetic agonists of liver X receptors that are receptors for oxysterols, did not augment the IL-8 release. 25-HC enhanced the nuclear factor-kappa B (NF-κB) DNA binding activity and translocation of phosphorylated c-Jun into the nucleus. The release of IL-8 was inhibited by the NF-κB inhibitor, caffeic acid phenethyl ester (CAPE), an inhibitor of nuclear factor kappa-B alpha (IκBα) inhibitor, BAY 11–7085, and an inhibitor of nuclear factor kappa-B kinase-2 (IKK-2) inhibitor, SC-514, but not by a c-Jun N-terminal kinase (JNK) inhibitory peptide, L-JNKi1. 25-HC significantly potentiated IL-8 release in poly(I:C)-treated cells and the augmentation was inhibited by CAPE, BAY 11–7085, and SC-514. Furthermore, 25-HC potentiated the translocation of interferon regulatory factor 3 into the nucleus and the release of interferon-beta (IFN-β) in poly(I:C)-treated cells.</p> <p>Conclusions</p> <p>These data demonstrated that 25-HC augments the release of IL-8 and IL-6 via NF-κB signalling pathway and enhances the release of IL-8 and IFN-β after stimulation of TLR3 in airway epithelial cells. 25-HC may be involved in the neutrophilic airway inflammation through the stimulant effect of IL-8 and IL-6 release and also potentiate the TLR3-mediated innate immunity in airway diseases.</p>http://respiratory-research.com/content/13/1/63Airway inflammationInterferon regulatory factor 3Interleukin-8Nuclear factor-kappa BOxysterol |
| spellingShingle | Koarai Akira Yanagisawa Satoru Sugiura Hisatoshi Ichikawa Tomohiro Kikuchi Takashi Furukawa Kanako Akamatsu Keiichiro Hirano Tsunahiko Nakanishi Masanori Matsunaga Kazuto Minakata Yoshiaki Ichinose Masakazu 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells Respiratory Research Airway inflammation Interferon regulatory factor 3 Interleukin-8 Nuclear factor-kappa B Oxysterol |
| title | 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells |
| title_full | 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells |
| title_fullStr | 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells |
| title_full_unstemmed | 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells |
| title_short | 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells |
| title_sort | 25 hydroxycholesterol enhances cytokine release and toll like receptor 3 response in airway epithelial cells |
| topic | Airway inflammation Interferon regulatory factor 3 Interleukin-8 Nuclear factor-kappa B Oxysterol |
| url | http://respiratory-research.com/content/13/1/63 |
| work_keys_str_mv | AT koaraiakira 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT yanagisawasatoru 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT sugiurahisatoshi 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT ichikawatomohiro 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT kikuchitakashi 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT furukawakanako 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT akamatsukeiichiro 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT hiranotsunahiko 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT nakanishimasanori 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT matsunagakazuto 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT minakatayoshiaki 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells AT ichinosemasakazu 25hydroxycholesterolenhancescytokinereleaseandtolllikereceptor3responseinairwayepithelialcells |